A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

Australia

Zai Lab Site 5013, Phillip, Australian Capital Territory

Zai Lab Site 5021, Kogarah, New South Wales

Zai Lab Site 5016, Kotara, New South Wales

Zai Lab Site 5020, Birtinya, Queensland

Zai Lab Site 5019, Coorparoo, Queensland